Compare CPIX & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPIX | CIGL |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 59.4M |
| IPO Year | 2009 | 2025 |
| Metric | CPIX | CIGL |
|---|---|---|
| Price | $3.85 | $2.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 230.6K | ★ 901.9K |
| Earning Date | 03-03-2026 | 09-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,278,349.00 | $11,072,733.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.21 | 6.32 |
| 52 Week Low | $1.85 | $1.40 |
| 52 Week High | $7.25 | $31.06 |
| Indicator | CPIX | CIGL |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 52.90 |
| Support Level | $3.54 | $1.85 |
| Resistance Level | $3.98 | $2.65 |
| Average True Range (ATR) | 0.34 | 0.30 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 22.73 | 19.89 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.